Importance of duodenogastric reflux in gastro-oesophageal reflux disease

被引:31
作者
Fein, M.
Maroske, J.
Fuchs, K. -H.
机构
[1] Univ Wurzburg, Dept Surg, D-97080 Wurzburg, Germany
[2] Markus Krankenhaus, Dept Surg, Frankfurt, Germany
关键词
D O I
10.1002/bjs.5486
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Bile in the oesophagus occurs frequently in patients with gastro-oesophageal reflux disease (GORD) and has been linked to Barrett's metaplasia and cancer. Although duodenogastric reflux is a prerequisite for bile in the oesophagus, little is known about its importance in GORD. Methods: Some 341 patients with GORD were assessed by simultaneous 24-h gastric and oesophageal bilirubin monitoring. Definitions of increased bilirubin exposure were based on the 95th percentiles in healthy volunteers. The relationship between gastric and oesophageal bilirubin exposure and the correlation with disease severity were analysed. Results: Of the 341 patients with GORD, 130 (38.1 per cent) had increased gastric and 173 (50.7 per cent) had increased oesophageal bilirubin exposure. Of the 173 patients with bile in the oesophagus, 89 (51.4 per cent) had normal and 84 (48.6 per cent) had increased gastric bilirubin exposure. Of these 84 patients, 75 (89 per cent) had oesophagitis or Barrett's oesophagus (P = 0.003). These effects were mainly related to differences in supine reflux. Conclusion: Bile in the oesophagus originates from either normal or increased gastric bilirubin exposure. Patients with increased duodenogastric reflux are more likely to have oesophagitis or Barrett's oesophagus. These findings highlight the role of duodenogastric reflux as an additional factor in the pathogenesis of GORD.
引用
收藏
页码:1475 / 1482
页数:8
相关论文
共 36 条
[1]   Dietary interference with the use of Bilitec to assess bile reflux [J].
Barrett, MW ;
Myers, JC ;
Watson, DI ;
Jamieson, GG .
DISEASES OF THE ESOPHAGUS, 1999, 12 (01) :60-64
[2]   LONG-TERM AMBULATORY ENTEROGASTRIC REFLUX MONITORING - VALIDATION OF A NEW FIBEROPTIC TECHNIQUE [J].
BECHI, P ;
PUCCIANI, F ;
BALDINI, F ;
COSI, F ;
FALCIAI, R ;
MAZZANTI, R ;
CASTAGNOLI, A ;
PASSERI, A ;
BOSCHERINI, S .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (07) :1297-1306
[3]   Bile reflux into the stomach and the esophagus for volunteers older than 40 years [J].
Bollschweiler, E ;
Wolfgarten, E ;
Pütz, B ;
Gutschow, C ;
Hölscher, AH .
DIGESTION, 2005, 71 (02) :65-71
[4]  
BREMNER CG, 1989, S AFR J SURG, V27, P119
[5]   Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus [J].
Buttar, NS ;
Wang, KK ;
Leontovich, O ;
Westcott, JY ;
Pacifico, RJ ;
Anderson, MA ;
Krishnadath, KK ;
Lutzke, LS ;
Burgart, LJ .
GASTROENTEROLOGY, 2002, 122 (04) :1101-1112
[6]   Duodenogastric reflux of bile in health: the normal range [J].
Byrne, JP ;
Romagnoli, R ;
Bechi, P ;
Attwood, SEA ;
Fuchs, KH ;
Collard, JM .
PHYSIOLOGICAL MEASUREMENT, 1999, 20 (02) :149-158
[7]   AMBULATORY ESOPHAGEAL BILE REFLUX MONITORING IN BARRETTS-ESOPHAGUS [J].
CALDWELL, MTP ;
LAWLOR, P ;
BYRNE, PJ ;
WALSH, TN ;
HENNESSY, TPJ .
BRITISH JOURNAL OF SURGERY, 1995, 82 (05) :657-660
[8]   DUODENOGASTROESOPHAGEAL REFLUX - RELATIONSHIP TO PH AND IMPORTANCE IN BARRETTS-ESOPHAGUS [J].
CHAMPION, G ;
RICHTER, JE ;
VAEZI, MF ;
SINGH, S ;
ALEXANDER, R .
GASTROENTEROLOGY, 1994, 107 (03) :747-754
[9]   Columnar mucosa and intestinal metaplasia of the esophagus - Fifty years of controversy [J].
DeMeester, SR ;
DeMeester, TR .
ANNALS OF SURGERY, 2000, 231 (03) :303-321
[10]   An evidence-based appraisal of reflux disease management - the Genval workshop report [J].
Dent, J ;
Brun, J ;
Fendrick, AM ;
Fennerty, MB ;
Janssens, J ;
Kahrilas, PJ ;
Lauritsen, K ;
Reynolds, JC ;
Shaw, M ;
Talley, NJ .
GUT, 1999, 44 :S1-S16